Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2026 年第 2 季持倉
持倉截至 2026/6/30，2026/8/13 申報。只含多頭部位，變化是跟 2026 年第 1 季比股數。
- 持股檔數
- 104
- 較 2026 年第 1 季 +9
- 總值
- $20.4 億
- 較 2026 年第 1 季 +$3.40 億 (+19.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ROIVRoivant Sciences Ltd. | SHS | 3,750,000 | $1.33 億 | 6.5% | +950,000+33.9% | 加碼 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 987,000 | $1.31 億 | 6.4% | −297,926−23.2% | 減碼 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 1,279,134 | $1.14 億 | 5.6% | 00.0% | 不變 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 1,595,000 | $9,627 萬 | 4.7% | −80,000−4.8% | 減碼 | 歷史 |
| ERASErasca, Inc. | COM | 5,250,000 | $9,618 萬 | 4.7% | −100,000−1.9% | 減碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 650,000 | $6,930 萬 | 3.4% | +170,000+35.4% | 加碼 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 185,000 | $6,194 萬 | 3.0% | +15,000+8.8% | 加碼 | 歷史 |
| ALKSAlkermes plc. | SHS | 1,125,000 | $5,894 萬 | 2.9% | −225,000−16.7% | 減碼 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 590,000 | $5,615 萬 | 2.7% | +90,327+18.1% | 加碼 | 歷史 |
| ANABAnaptysbio, Inc | COM | 826,109 | $5,576 萬 | 2.7% | −113,891−12.1% | 減碼 | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 2,900,000 | $5,359 萬 | 2.6% | +1,559,160+116.3% | 加碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 550,000 | $4,685 萬 | 2.3% | −150,483−21.5% | 減碼 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 250,000 | $4,682 萬 | 2.3% | +150,000+150.0% | 加碼 | 歷史 |
| ABVXAbivax S.A. | SPONSORED ADS | 330,000 | $4,398 萬 | 2.2% | −75,000−18.5% | 減碼 | 歷史 |
| TRAXFirst Tracks Biotherapeutics, Inc. | ORD SHS | 2,032,012 | $4,088 萬 | 2.0% | +2,032,012 | 新進 | 歷史 |
| DNTHDianthus Therapeutics, Inc. | COM | 400,000 | $3,899 萬 | 1.9% | +50,000+14.3% | 加碼 | 歷史 |
| STROSutro Biopharma, Inc. | COM SHS | 1,172,487 | $3,893 萬 | 1.9% | +102,968+9.6% | 加碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 275,000 | $3,396 萬 | 1.7% | −25,000−8.3% | 減碼 | 歷史 |
| TRVITrevi Therapeutics, Inc. | COM | 1,800,172 | $3,357 萬 | 1.6% | −200,000−10.0% | 減碼 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 10,144,562 | $2,729 萬 | 1.3% | −491,756−4.6% | 減碼 | 歷史 |
| LXEOLexeo Therapeutics, Inc. | COM | 5,807,611 | $2,703 萬 | 1.3% | +757,400+15.0% | 加碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 700,000 | $2,605 萬 | 1.3% | +200,000+40.0% | 加碼 | 歷史 |
| BLTEBelite Bio, Inc | SPONSORED ADS | 165,000 | $2,541 萬 | 1.2% | +100,000+153.8% | 加碼 | 歷史 |
| ELVNEnliven Therapeutics, Inc. | COM | 500,000 | $2,538 萬 | 1.2% | −86,904−14.8% | 減碼 | 歷史 |
| FBRXForte Biosciences, Inc. | COM NEW | 1,145,391 | $2,434 萬 | 1.2% | +133,501+13.2% | 加碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 967,620 | $2,347 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| ANROAlto Neuroscience, Inc. | COM SHS | 850,000 | $2,243 萬 | 1.1% | +350,000+70.0% | 加碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 40,000 | $2,148 萬 | 1.1% | −15,000−27.3% | 減碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 172,125 | $2,110 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| MLYSMineralys Therapeutics, Inc. | COM | 750,000 | $2,024 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 1,050,000 | $1,965 萬 | 1.0% | +650,000+162.5% | 加碼 | 歷史 |
| SGMTSagimet Biosciences Inc. | COM SER A | 2,497,864 | $1,931 萬 | 0.9% | +1,629,844+187.8% | 加碼 | 歷史 |
| JBIOJade Biosciences, Inc. | COM NEW | 840,350 | $1,867 萬 | 0.9% | +200,394+31.3% | 加碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 450,000 | $1,742 萬 | 0.9% | −300,000−40.0% | 減碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 300,000 | $1,704 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 875,760 | $1,595 萬 | 0.8% | +94,500+12.1% | 加碼 | 歷史 |
| SVRASavara Inc | COM | 2,512,153 | $1,547 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 400,000 | $1,491 萬 | 0.7% | +400,000 | 新進 | 歷史 |
| CATXPerspective Therapeutics, Inc. | COM NEW | 4,214,582 | $1,437 萬 | 0.7% | +1,050,000+33.2% | 加碼 | 歷史 |
| ODTXOdyssey Therapeutics, Inc. | COMMON STOCK | 766,346 | $1,434 萬 | 0.7% | +766,346 | 新進 | 歷史 |
| Cogent Biosciences, Inc.19240QAA0 | NOTE 1.625%11/1 | – | $1,365 萬 | 0.7% | – | – | – |
| HLXCHelix Acquisition Corp. III | USD CL A ORD SHS | 1,250,000 | $1,330 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| EQEquillium, Inc. | COM | 4,100,000 | $1,312 萬 | 0.6% | +2,873,690+234.3% | 加碼 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 148,013 | $1,270 萬 | 0.6% | +48,013+48.0% | 加碼 | 歷史 |
| CLYMClimb Bio, Inc. | COM | 972,000 | $1,267 萬 | 0.6% | +272,000+38.9% | 加碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 374,000 | $1,267 萬 | 0.6% | −1,026,000−73.3% | 減碼 | 歷史 |
| MANEVeradermics, Inc | COMMON STOCK | 100,000 | $1,229 萬 | 0.6% | +30,000+42.9% | 加碼 | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 150,000 | $1,223 萬 | 0.6% | −50,000−25.0% | 減碼 | 歷史 |
| Omeros Corp682143AK8 | NOTE 9.500% 6/1 | – | $1,218 萬 | 0.6% | – | – | – |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,750,000 | $1,192 萬 | 0.6% | +750,000+75.0% | 加碼 | 歷史 |
| DMRADamora Therapeutics, Inc. | COM NEW | 425,000 | $1,105 萬 | 0.5% | −25,000−5.6% | 減碼 | 歷史 |
| EPRXEupraxia Pharmaceuticals Inc. | COM | 1,650,000 | $1,091 萬 | 0.5% | +60,995+3.8% | 加碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 250,000 | $1,073 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| PRQRProQR Therapeutics N.V. | SHS EURO | 5,543,936 | $1,031 萬 | 0.5% | +3,089,658+125.9% | 加碼 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 275,000 | $932.0 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| KRROKorro Bio, Inc. | COM | 706,904 | $931.7 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| AVRAnteris Technologies Global Corp. | COM | 912,397 | $898.7 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 1,464,303 | $863.9 萬 | 0.4% | −1,100,000−42.9% | 減碼 | 歷史 |
| QUREuniQure N.V. | SHS | 175,000 | $806.0 萬 | 0.4% | +175,000 | 新進 | 歷史 |
| ASNDAscendis Pharma A/S | ORD SHS | 30,000 | $800.2 萬 | 0.4% | −65,000−68.4% | 減碼 | 歷史 |
| IBIOiBio, Inc. | COM NEW | 4,007,881 | $701.4 萬 | 0.3% | +900,681+29.0% | 加碼 | 歷史 |
| GENBGenerate Biomedicines, Inc. | COM SHS | 400,000 | $674.8 萬 | 0.3% | +50,000+14.3% | 加碼 | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 200,012 | $638.8 萬 | 0.3% | −57,500−22.3% | 減碼 | 歷史 |
| SLGLSol-Gel Technologies Ltd. | SHS NEW | 84,900 | $629.4 萬 | 0.3% | +49,900+142.6% | 加碼 | 歷史 |
| SABSSAB Biotherapeutics, Inc. | COM NEW | 1,525,000 | $594.8 萬 | 0.3% | +950,000+165.2% | 加碼 | 歷史 |
| MGNXMacrogenics Inc | COM | 1,216,606 | $562.1 萬 | 0.3% | +716,606+143.3% | 加碼 | 歷史 |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 100,000 | $545.4 萬 | 0.3% | −50,000−33.3% | 減碼 | 歷史 |
| NAMSWNewAmsterdam Pharma Co N.V. | *W EXP 11/22/202 | 245,000 | $534.3 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ASMBAssembly Biosciences, Inc. | COM NEW | 190,000 | $522.1 萬 | 0.3% | +190,000 | 新進 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 1,000,000 | $520.0 萬 | 0.3% | −547,641−35.4% | 減碼 | 歷史 |
| DTILPrecision Biosciences Inc | COM NEW | 646,576 | $508.2 萬 | 0.2% | +48,630+8.1% | 加碼 | 歷史 |
| COAGHemab Therapeutics Holdings, Inc. | COM SHS | 138,030 | $507.0 萬 | 0.2% | +138,030 | 新進 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 250,000 | $459.3 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| AVBPArriVent BioPharma, Inc. | COM | 125,000 | $434.3 萬 | 0.2% | −50,000−28.6% | 減碼 | 歷史 |
| VRCAVerrica Pharmaceuticals Inc. | COM SHS | 707,338 | $432.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 301,183 | $426.2 萬 | 0.2% | −807,300−72.8% | 減碼 | 歷史 |
| MBXMBX Biosciences, Inc. | COM | 75,000 | $414.0 萬 | 0.2% | −75,000−50.0% | 減碼 | 歷史 |
| RACCResearch Alliance Corp III | ORD SHS CL A | 370,000 | $395.9 萬 | 0.2% | +370,000 | 新進 | 歷史 |
| IMVTImmunovant, Inc. | COM | 100,000 | $385.3 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| AMANAmanat Acquisition Corp. | CL A ORD | 375,000 | $381.0 萬 | 0.2% | +375,000 | 新進 | 歷史 |
| BHVNBiohaven Ltd. | COM | 250,000 | $372.0 萬 | 0.2% | +250,000 | 新進 | 歷史 |
| FTHFaeth Therapeutics, Inc. | COM NEW | 144,404 | $361.0 萬 | 0.2% | +144,404 | 新進 | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM NEW | 312,500 | $305.3 萬 | 0.1% | −187,500−37.5% | 減碼 | 歷史 |
| ALECAlector, Inc. | COM | 1,510,000 | $303.5 萬 | 0.1% | +1,010,000+202.0% | 加碼 | 歷史 |
| SGPSpyGlass Pharma, Inc. | COM SHS | 131,586 | $292.9 萬 | 0.1% | −118,414−47.4% | 減碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 75,000 | $280.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| OACCUOaktree Acquisition Corp. III Life Sciences | UNIT 10/04/2029 | 250,000 | $275.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Celcuity Inc.15102KAB6 | NOTE 0.250% 8/0 | – | $228.3 萬 | 0.1% | – | 新進 | – |
| JATTJATT II Acquisition Corp. | ORD SHS | 200,000 | $227.2 萬 | 0.1% | +200,000 | 新進 | 歷史 |
| NMRANeumora Therapeutics, Inc. | COM | 1,070,651 | $182.0 萬 | 0.1% | +1,070,651 | 新進 | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 98,999 | $177.8 萬 | 0.1% | +98,999 | 新進 | 歷史 |
| ANLAdlai Nortye Group Ltd. | ADS | 153,847 | $176.9 萬 | 0.1% | −10,901−6.6% | 減碼 | 歷史 |
| SPRBSpruce Biosciences, Inc. | COM NEW | 30,000 | $162.0 萬 | 0.1% | +30,000 | 新進 | 歷史 |
| EIKNEikon Therapeutics, Inc. | COM | 98,001 | $127.9 萬 | 0.1% | +98,001 | 新進 | 歷史 |
| OKUROnKure Therapeutics, Inc. | COM CL A | 240,963 | $109.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 600,000 | $103.8 萬 | 0.1% | −10,370−1.7% | 減碼 | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM NEW | 145,000 | $67.7 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| BOLDBoundless Bio, Inc. | COM | 250,000 | $62.5 萬 | <0.1% | +250,000 | 新進 | 歷史 |
| LENZLENZ Therapeutics, Inc. | COM | 100,000 | $56.8 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| QTTBQ32 Bio Inc. | COM | 27,777 | $35.4 萬 | <0.1% | 00.0% | 不變 | 歷史 |
選擇權（8 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| MRNAModerna, Inc. | Stock | $3,502 萬 | $3,326 萬 |
| ARK ETF Tr00214Q302 | GENOMIC REV ETF | – | $3,155 萬 |
| LLYEli Lilly & Co | Stock | – | $2,399 萬 |
| OMEROmeros Corp | COM | $1,342 萬 | – |
| ALKSAlkermes plc. | SHS | – | $1,310 萬 |
| QUREuniQure N.V. | SHS | – | $921.2 萬 |
| EVMNEvommune, Inc. | COM SHS | $664.6 萬 | – |
| SMMTSummit Therapeutics Inc. | COM | – | $145.7 萬 |
2026 年第 1 季之後清倉（8 檔）
2026 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2026 年第 1 季股數 | 2026 年第 1 季市值 | 2026 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,400,000 | $5,561 萬 | 3.3% | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 362,764 | $4,165 萬 | 2.4% | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 562,631 | $2,966 萬 | 1.7% | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 150,000 | $1,114 萬 | 0.7% | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 1,401,727 | $1,016 萬 | 0.6% | 歷史 |
| Celcuity Inc.15102KAA8 | NOTE 2.750% 8/0 | – | $731.4 萬 | 0.4% | – |
| CORTCorcept Therapeutics Inc | COM | 50,000 | $201.6 萬 | 0.1% | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 229,076 | $170.0 萬 | 0.1% | 歷史 |